These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 17024549)

  • 1. Neuroleptic-induced dysphagia: case report and literature review.
    Dziewas R; Warnecke T; Schnabel M; Ritter M; Nabavi DG; Schilling M; Ringelstein EB; Reker T
    Dysphagia; 2007 Jan; 22(1):63-7. PubMed ID: 17024549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extrapyramidal syndrome presenting as dysphagia: a case report.
    Gonzalez F
    Am J Hosp Palliat Care; 2008; 25(5):398-400. PubMed ID: 19047493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuroleptic-induced dysphagia.
    Sokoloff LG; Pavlakovic R
    Dysphagia; 1997; 12(4):177-9. PubMed ID: 9294935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relationship between negative symptoms of schizophrenia and extrapyramidal side effects with haloperidol and olanzapine.
    Allan ER; Sison CE; Alpert M; Connolly B; Crichton J
    Psychopharmacol Bull; 1998; 34(1):71-4. PubMed ID: 9564201
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic-associated dysphagia confirmed by esophageal manometry.
    Moss HB; Green A
    Am J Psychiatry; 1982 Apr; 139(4):515-6. PubMed ID: 6121491
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined treatment of quetiapine with haloperidol in animal models of antipsychotic effect and extrapyramidal side effects: comparison with risperidone and chlorpromazine.
    Tada M; Shirakawa K; Matsuoka N; Mutoh S
    Psychopharmacology (Berl); 2004 Oct; 176(1):94-100. PubMed ID: 15083255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Dysphagia or dysphagias during neuroleptic medication?].
    Chaumartin N; Monville M; Lachaux B
    Encephale; 2012 Sep; 38(4):351-5. PubMed ID: 22980477
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?
    Nair S; Saeed O; Shahab H; Sedky K; Garver D; Lippmann S
    Gen Hosp Psychiatry; 2001; 23(4):231-2. PubMed ID: 11569473
    [No Abstract]   [Full Text] [Related]  

  • 9. Systematic review of case reports of oropharyngeal dysphagia following the use of antipsychotics.
    Miarons M; Rofes L
    Gastroenterol Hepatol; 2019 Apr; 42(4):209-227. PubMed ID: 30470564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biperiden and haloperidol plasma levels and extrapyramidal side effects in schizophrenic patients.
    Meszaros K; Lenzinger E; Hornik K; Schönbeck G; Hatzinger R; Langer G; Sieghart W; Aschauer HN
    Neuropsychobiology; 1997; 36(2):69-72. PubMed ID: 9267855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High dosage of aripiprazole-induced dysphagia.
    Lin TW; Lee BS; Liao YC; Chiu NY; Hsu WY
    Int J Eat Disord; 2012 Mar; 45(2):305-6. PubMed ID: 21541978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An analysis of safety and tolerability data from controlled, comparative studies of quetiapine in patients with schizophrenia, focusing on extrapyramidal symptoms.
    Timdahl K; Carlsson A; Stening G
    Hum Psychopharmacol; 2007 Jul; 22(5):315-25. PubMed ID: 17542047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurologic side effects in neuroleptic-naïve patients treated with haloperidol or risperidone.
    Windhaber J; Urbanits S; Grisold W
    Neurology; 2000 Apr; 54(7):1543-4. PubMed ID: 10751282
    [No Abstract]   [Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome and neuroleptic-induced catatonia: differential diagnosis and treatment.
    Stoudemire A; Luther JS
    Int J Psychiatry Med; 1984; 14(1):57-63. PubMed ID: 6145675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-induced dysphagia.
    Bulling M
    Aust N Z J Med; 1999 Oct; 29(5):748. PubMed ID: 10630662
    [No Abstract]   [Full Text] [Related]  

  • 16. Antipsychotic medication and oropharyngeal dysphagia: systematic review.
    Miarons Font M; Rofes Salsench L
    Eur J Gastroenterol Hepatol; 2017 Dec; 29(12):1332-1339. PubMed ID: 29023321
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intramuscular olanzapine and intramuscular haloperidol in acute schizophrenia: antipsychotic efficacy and extrapyramidal safety during the first 24 hours of treatment.
    Wright P; Lindborg SR; Birkett M; Meehan K; Jones B; Alaka K; Ferchland-Howe I; Pickard A; Taylor CC; Roth J; Battaglia J; Bitter I; Chouinard G; Morris PL; Breier A
    Can J Psychiatry; 2003 Dec; 48(11):716-21. PubMed ID: 14733451
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The use of nifedipine as a corrector of extrapyramidal side-effects of classical neuroleptics].
    Popov MIu
    Zh Nevrol Psikhiatr Im S S Korsakova; 2008; 108(6):28-33. PubMed ID: 18577931
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Behavioural effects of chronic haloperidol and risperidone treatment in rats.
    Karl T; Duffy L; O'brien E; Matsumoto I; Dedova I
    Behav Brain Res; 2006 Aug; 171(2):286-94. PubMed ID: 16697060
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Testing basic visual functions in the evaluation of extrapyramidal side effects of antipsychotic agents].
    Kéri S; Antal A; Szekeres G; Szendi I; Kovács Z; Janka Z; Benedek G
    Orv Hetil; 1998 Feb; 139(5):235-8. PubMed ID: 9489377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.